ARM 390
Alternative Names: ARM 100390Latest Information Update: 21 Jan 2008
At a glance
- Originator AstraZeneca
- Class Anti-inflammatories; Benzamides
- Mechanism of Action Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 06 Dec 2002 No development reported - Preclinical for Pain in Canada (unspecified route)
- 06 Dec 2002 No development reported - Preclinical for Pain in USA (unspecified route)
- 01 Dec 2000 Preclinical development for Pain in Canada (Unknown route)